Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Clayton
Clinical trial register · Australia

Clinical Trials in Clayton, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3379 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:18 UTC
3379
Studies in scope
all four open statuses
1825
Recruiting now
open to new participants
783
Lead sponsors
across recruiting studies
Top sites
Melbourne 34 Westmead 30 Brisbane 29 Clayton 22 Frankston 21

Trials with a site in Clayton

22 of 3379 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 1
250
Sydney, Clayton, Melbourne, Nedlands
2025-12-16
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
153
Clayton, Nedlands
2025-08-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Blacktown, Camperdown, Clayton, Melbourne, Nedlands
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Wollongong, Birtinya, Clayton, St Albans
2025-07-16
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC
Phase 3
2,400
Camperdown, North Ryde, Westmead, Clayton
2025-06-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Westmead, Adelaide, Clayton, Heidelberg, Perth
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Concord, Brisbane, Adelaide, Clayton, Melbourne
2024-06-05
Recruiting
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
NCT06351631Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis, Post-polycythemia Vera Myelofibrosis
Merck Sharp & Dohme LLC
Phase 3
400
Camperdown, St Leonards, Buderim, Southport, Adelaide, Clayton
2024-05-23
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Camperdown, Liverpool, St Leonards, Waratah, Adelaide, Clayton, Melbourne, Perth
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Macquarie University, Westmead, Brisbane, Clayton, Melbourne
2023-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Kingswood, Sydney, Brisbane, Adelaide, Clayton, Melbourne
2023-10-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Bruce, Blacktown, Camperdown, Kanwal, Brisbane, Clayton, Hoppers Crossing
2023-10-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
St Leonards, Westmead, Brisbane, Clayton, Melbourne, Subiaco
2022-02-03
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Camperdown, Liverpool, Westmead, Clayton
2021-12-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Liverpool, St Leonards, Clayton, Heidelberg, Nedlands
2020-05-19
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-australia/city/clayton

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,379 studies in total at the last sync on 18 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Clayton that also match the filters currently applied.

How many clinical trials are recruiting in Clayton?

10 of the 22 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Clayton), 22 studies
PhaseStudiesRecruitingShare
Phase 317677.3%
Phase 1229.1%
Phase 1/2219.1%
Phase 2/3114.5%

Most active sponsors

Lead sponsors with the most studies (Clayton)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2210
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.